Odyssey Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ODYSSEY PHARMS, and what generic and branded alternatives to ODYSSEY PHARMS drugs are available?
ODYSSEY PHARMS has nine approved drugs.
Summary for Odyssey Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 9 |
Drugs and US Patents for Odyssey Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odyssey Pharms | NYSTATIN | nystatin | TABLET;VAGINAL | 062615-001 | Oct 17, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 006536-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | INJECTABLE;INJECTION | 006536-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 089096-001 | Dec 19, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
